These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
413 related articles for article (PubMed ID: 29033189)
1. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses. Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189 [TBL] [Abstract][Full Text] [Related]
2. Identification and interaction analysis of key miRNAs in medullary thyroid carcinoma by bioinformatics analysis. Zhang L; Lu D; Liu M; Zhang M; Peng Q Mol Med Rep; 2019 Sep; 20(3):2316-2324. PubMed ID: 31322209 [TBL] [Abstract][Full Text] [Related]
3. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis. Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248 [TBL] [Abstract][Full Text] [Related]
4. Two GEO MicroRNA Expression Profile Based High-Throughput Screen to Identify MicroRNA-31-3p Regulating Growth of Medullary Thyroid Carcinoma Cell by Targeting RASA2. Jiang M; Shi X; Zhu H; Wei W; Li J Med Sci Monit; 2019 Jul; 25():5170-5180. PubMed ID: 31298226 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. Liang L; Zeng JH; Wang JY; He RQ; Ma J; Chen G; Cai XY; Hu XH Pathol Res Pract; 2017 Dec; 213(12):1494-1509. PubMed ID: 29113686 [TBL] [Abstract][Full Text] [Related]
6. Expression of microRNA-99a-3p in Prostate Cancer Based on Bioinformatics Data and Meta-Analysis of a Literature Review of 965 Cases. Yan HB; Zhang Y; Cen JM; Wang X; Gan BL; Huang JC; Li JY; Song QH; Li SH; Chen G Med Sci Monit; 2018 Jul; 24():4807-4822. PubMed ID: 29997385 [TBL] [Abstract][Full Text] [Related]
7. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of MicroRNA-1 and Its Potential Molecular Mechanism in Nasopharyngeal Cancer: An Investigation Combined with In Silico and In-House Immunohistochemistry Validation. Wen JY; Qin LT; Chen G; Huang HQ; Shen MJ; Pang JS; Tang YX; Lu W; Wang RS; Luo JY Dis Markers; 2022; 2022():7962220. PubMed ID: 35251377 [TBL] [Abstract][Full Text] [Related]
9. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
10. In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma. Hu S; Liao Y; Zheng J; Gou L; Regmi A; Zafar MI; Chen L Biomed Res Int; 2019; 2019():2725192. PubMed ID: 31032340 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data. Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053 [TBL] [Abstract][Full Text] [Related]
12. The expression of miR-375 in prostate cancer: A study based on GEO, TCGA data and bioinformatics analysis. He S; Shi J; Mao J; Luo X; Liu W; Liu R; Yang F Pathol Res Pract; 2019 Jun; 215(6):152375. PubMed ID: 30879885 [TBL] [Abstract][Full Text] [Related]
13. Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. Mou T; Zhu D; Wei X; Li T; Zheng D; Pu J; Guo Z; Wu Z World J Surg Oncol; 2017 Mar; 15(1):63. PubMed ID: 28302149 [TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular carcinoma via targeting AKT-mTOR pathway. Zhang Y; Guo X; Xiong L; Yu L; Li Z; Guo Q; Li Z; Li B; Lin N Mol Cancer; 2014 Nov; 13():253. PubMed ID: 25424347 [TBL] [Abstract][Full Text] [Related]
15. Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics. Zhang R; Zhang LJ; Yang ML; Huang LS; Chen G; Feng ZB Mol Med Rep; 2018 Feb; 17(2):2211-2228. PubMed ID: 29207133 [TBL] [Abstract][Full Text] [Related]
16. Identification of microRNAs associated with medullary thyroid carcinoma by bioinformatics analyses. Fu X; Fang J; Lian M; Zhong Q; Ma H; Feng L; Wang R; Wang H Mol Med Rep; 2017 Jun; 15(6):4266-4272. PubMed ID: 28487941 [TBL] [Abstract][Full Text] [Related]
17. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR. Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946 [TBL] [Abstract][Full Text] [Related]
19. Clinical Value and Prospective Pathway Signaling of MicroRNA-375 in Lung Adenocarcinoma: A Study Based on the Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and Bioinformatics Analysis. Gan TQ; Chen WJ; Qin H; Huang SN; Yang LH; Fang YY; Pan LJ; Li ZY; Chen G Med Sci Monit; 2017 May; 23():2453-2464. PubMed ID: 28533502 [TBL] [Abstract][Full Text] [Related]
20. Expression and potential molecular mechanisms of miR‑204‑5p in breast cancer, based on bioinformatics and a meta‑analysis of 2,306 cases. Cai KT; Liu AG; Wang ZF; Jiang HW; Zeng JJ; He RQ; Ma J; Chen G; Zhong JC Mol Med Rep; 2019 Feb; 19(2):1168-1184. PubMed ID: 30569120 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]